Biotechnology VALUE FUND II L.P., Director Other at Kymera Therapeutics, Inc. (KYMR), bought 545,525 shares at $26.00 ($14.2M) on 2022-08-22, disclosed to the SEC on 2022-08-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.00 | 27,117 | $705K | 5.0% |
| 2 | $26.00 | 233,362 | $6.1M | 42.8% |
| 3 | $26.00 | 285,046 | $7.4M | 52.3% |
| Total | $26.00 avg | 545,525 | $14.2M | 100% |
| Filing → |
| THRD | BUY | 2022-12-22 | $1.7M | — | Filing → |
| RPTX | BUY | 2022-06-15 | $3.8M | — | Filing → |
| RPTX | BUY | 2022-01-21 | $28.1M | — | Filing → |